Quarterly Statement Of Cash Flows

Medrx Co.,Ltd. - Filing #7593851

Concept 2022-01-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
As at
2021-06-30
2021-01-01 to
2021-06-30
As at
2020-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-380,216,000 JPY
-471,295,000 JPY
Depreciation
23,117,000 JPY
30,121,000 JPY
Increase (decrease) in allowance for doubtful accounts
2,288,000 JPY
JPY
Interest and dividend income
-8,000 JPY
-5,000 JPY
Interest expenses
JPY
969,000 JPY
Foreign exchange losses (gains)
JPY
-11,000 JPY
Decrease (increase) in inventories
-3,533,000 JPY
4,464,000 JPY
Other, net
-32,002,000 JPY
-7,264,000 JPY
Subtotal
-436,589,000 JPY
-427,348,000 JPY
Interest and dividends received
8,000 JPY
5,000 JPY
Interest paid
JPY
-969,000 JPY
Income taxes paid
-2,502,000 JPY
-3,551,000 JPY
Net cash provided by (used in) operating activities
-437,904,000 JPY
-424,174,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-618,000 JPY
-1,410,000 JPY
Net cash provided by (used in) investing activities
-618,000 JPY
-1,410,000 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
JPY
550,000,000 JPY
Net cash provided by (used in) financing activities
280,000 JPY
864,330,000 JPY
Effect of exchange rate change on cash and cash equivalents
3,648,000 JPY
1,474,000 JPY
Net increase (decrease) in cash and cash equivalents
-434,594,000 JPY
440,219,000 JPY
Cash and cash equivalents
1,269,049,000 JPY
1,703,644,000 JPY
2,252,580,000 JPY
1,812,360,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.